Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection

Parasites and Vectors

Volumn 6, Issue 1, 2013, Pages

  Jia, Boyin ^a   Lu, Huijun ^a   Liu, Quan ^c   Yin, Jigang ^a   Jiang, Ning ^a   Chen, Qijun ^a,b  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF PATHOGEN BIOLOGY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Brain tissues; Gene ontology and pathway analysis; ME49 strain; Microarray; Peripheral lymphocytes; RH strain; Toxoplasma gondii

Indexed keywords

CD4 ANTIGEN; CD8ALPHA ANTIGEN; E1A ASSOCIATED P300 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR RECEPTOR 2; I KAPPA B KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C JUN; PROTEIN FOS; RAC2 PROTEIN; SOMATOMEDIN C RECEPTOR; STAT5B PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COMPARATIVE STUDY; GENE EXPRESSION; GENETIC ASSOCIATION; IMMUNITY; LYMPHOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA GONDII; TOXOPLASMOSIS; UPREGULATION;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; FEMALE; HOST-PATHOGEN INTERACTIONS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL; TRANSCRIPTOME;

MUS; TOXOPLASMA GONDII;

EID: 84878394561     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-6-161     Document Type: Article

References (52)

1. Toxoplasma, Hammondia, Besnotia, Sarcosystis, and other tissue cyst-forming coccidia of man and animals. Dubey J, Parasitic protozoa New York: Academic, Kreier JP, 1977 101 237
2. Dubey J, Beattie C, Toxoplasmosis of animals and man Boca Raton, FL: CRC Press 1988 220
3. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. Howe DK, Sibley LD, J Infect Dis 1995 172 1561 1566 10.1093/infdis/172.6.1561 7594717
4. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. Grigg ME, Ganatra J, Boothroyd JC, Margolis TP, J Infect Dis 2001 184 633 639 10.1086/322800 11474426 (Pubitemid 32783556)
5. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti D, Pelloux H, Marty P, Darde ML, J Infect Dis 2002 186 684 689 10.1086/342663 12195356 (Pubitemid 34925541)
6. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. Howe DK, Honore S, Derouin F, Sibley LD, J Clin Microbiol 1997 35 1411 1414 9163454 (Pubitemid 27216805)
7. Immune response to Toxoplasma gondii. Filisetti D, Candolfi E, Ann Ist Super Sanita 2004 40 71 80 15269455 (Pubitemid 39310674)
8. Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. Saeij JP, Boyle JP, Boothroyd JC, Trends Parasitol 2005 21 476 481 10.1016/j.pt.2005.08.001 16098810 (Pubitemid 41297751)
9. Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Radke JR, Striepen B, Guerini MN, Jerome ME, Roos DS, White MW, Mol Biochem Parasitol 2001 115 165 175 10.1016/S0166-6851(01)00284-5 11420103 (Pubitemid 32566226)
10. Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function. Yap GS, Sher A, Immunobiology 1999 201 240 247 10.1016/S0171-2985(99)80064-3 10631573
11. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. Kang H, Remington JS, Suzuki Y, J Immunol 2000 164 2629 2634 10679102 (Pubitemid 30115494)
12. The immunobiology of the innate response to Toxoplasma gondii. Miller CM, Boulter NR, Ikin RJ, Smith NC, Int J Parasitol 2009 39 23 39 10.1016/j.ijpara.2008.08.002 18775432
13. Toll-like receptor control of the adaptive immune responses. Iwasaki A, Medzhitov R, Nat Immunol 2004 5 987 995 10.1038/ni1112 15454922 (Pubitemid 41057715)
14. Toxoplasma gondii: genotyping of strains from Brazilian AIDS patients with cerebral toxoplasmosis by multilocus PCR-RFLP markers. Ferreira IM, Vidal JE, Costa-Silva TA, Meira CS, Hiramoto RM, de Penalva Oliveira AC, Pereira-Chioccola VL, Exp Parasitol 2008 118 221 227 10.1016/j.exppara.2007.08. 006 17950282 (Pubitemid 350309303)
15. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Schena M, Shalon D, Davis RW, Brown PO, Science 1995 270 467 470 10.1126/science.270.5235.467 7569999
16. Transcriptome profiling of zebrafish infected with Streptococcus suis. Wu Z, Zhang W, Lu Y, Lu C, Microb Pathog 2010 48 178 187 10.1016/j.micpath.2010. 02.007 20206250
17. Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK, Retrovirology 2011 8 18 10.1186/1742-4690-8-18 21410942
18. Analysis of differentially expressed genes in the precocious line of Eimeria maxima and its parent strain using suppression subtractive hybridization and cDNA microarrays. Dong H, Lin J, Han H, Jiang L, Zhao Q, Zhu S, Huang B, Parasitol Res 2011 108 1033 1040 10.1007/s00436-010-2149-7 21085989
19. DNA microarray-based genome-wide analyses of Plasmodium parasites. Bozdech Z, Mok S, Gupta AP, Methods Mol Biol 2013 923 189 211 22990779
20. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. Blader IJ, Manger ID, Boothroyd JC, J Biol Chem 2001 276 24223 24231 10.1074/jbc.M100951200 11294868
21. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Chaussabel D, Semnani RT, McDowell MA, Sacks D, Sher A, Nutman TB, Blood 2003 102 672 681 10.1182/blood-2002-10-3232 12663451 (Pubitemid 36841991)
22. Expression analysis of immune response genes of Muller cells infected with Toxoplasma gondii. Knight BC, Kissane S, Falciani F, Salmon M, Stanford MR, Wallace GR, J Neuroimmunol 2006 179 126 131 10.1016/j.jneuroim.2006.06.002 16934877 (Pubitemid 44441581)
23. The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells. Knight BC, Brunton CL, Modi NC, Wallace GR, Stanford MR, J Neuroimmunol 2005 160 41 47 10.1016/j.jneuroim.2004.10.023 15710456 (Pubitemid 40248592)
24. Infection with Toxoplasma gondii bradyzoites has a diminished impact on host transcript levels relative to tachyzoite infection. Fouts AE, Boothroyd JC, Infect Immun 2007 75 634 642 10.1128/IAI.01228-06 17088349 (Pubitemid 46203425)
25. Differential effects of three canonical Toxoplasma strains on gene expression in human neuroepithelial cells. Xiao J, Jones-Brando L, Talbot CC Jr, Yolken RH, Infect Immun 2011 79 1363 1373 10.1128/IAI.00947-10 21149591
26. The effect of Toxoplasma gondii on animal behavior: playing cat and mouse. Webster JP, Schizophr Bull 2007 33 752 756 10.1093/schbul/sbl073 17218613 (Pubitemid 47343711)
27. Neuropsychiatric disease and Toxoplasma gondii infection. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW, Neuroimmunomodulation 2009 16 122 133 10.1159/000180267 19212132
28. Host resistance in the brain against Toxoplasma gondii. Suzuki Y, J Infect Dis 2002 185 Suppl 1 58 S65 11865441
29. Rapid, efficient method for multiplex amplification from filter paper. Caggana M, Conroy JM, Pass KA, Hum Mutat 1998 11 404 409 10.1002/(SICI)1098- 1004(1998)11:5<404::AID-HUMU8>3.0.CO;2-S 9600459 (Pubitemid 28196641)
30. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Homan WL, Vercammen M, De Braekeleer J, Verschueren H, Int J Parasitol 2000 30 69 75 10.1016/S0020-7519(99)00170-8 10675747 (Pubitemid 30089725)
31. A comparative study of small RNAs in Toxoplasma gondii of distinct genotypes. Wang J, Liu X, Jia B, Lu H, Peng S, Piao X, Hou N, Cai P, Yin J, Jiang N, Chen Q, Parasit Vectors 2012 5 186 10.1186/1756-3305-5-186 22943187
32. The gene ontology (GO) project in 2006. Gene Ontology Consortium, Nucleic Acids Res 2006 34 322 D326 16381878
33. Gene ontology: tool for the unification of biology. The gene ontology consortium. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Nat Genet 2000 25 25 29 10.1038/75556 10802651 (Pubitemid 30257031)
34. Additional gene ontology structure for improved biological reasoning. Myhre S, Tveit H, Mollestad T, Laegreid A, Bioinformatics 2006 22 2020 2027 10.1093/bioinformatics/btl334 16787968 (Pubitemid 44283015)
35. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, Rosenberg J, Svrzikapa N, Blanc A, Carnec A, et al. Nat Biotechnol 2007 25 663 668 10.1038/nbt1305 17486083 (Pubitemid 46897203)
36. The KEGG resource for deciphering the genome. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M, Nucleic Acids Res 2004 32 277 D280 10.1093/nar/gkh063 14681412
37. Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. McHale CM, Zhang L, Lan Q, Li G, Hubbard AE, Forrest MS, Vermeulen R, Chen J, Shen M, Rappaport SM, et al. Genomics 2009 93 343 349 10.1016/j.ygeno.2008.12.006 19162166
38. WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data. Yi M, Horton JD, Cohen JC, Hobbs HH, Stephens RM, BMC Bioinforma 2006 7 30 10.1186/1471-2105-7-30 (Pubitemid 43336727)
39. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Livak KJ, Schmittgen TD, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609 (Pubitemid 34164012)
40. Toxoplasma gondii and schizophrenia. Torrey EF, Yolken RH, Emerg Infect Dis 2003 9 1375 1380 10.3201/eid0911.030143 14725265 (Pubitemid 37356208)
41. Effects of Toxoplasma gondii infection on the brain. Carruthers VB, Suzuki Y, Schizophr Bull 2007 33 745 751 10.1093/schbul/sbm008 17322557 (Pubitemid 47343715)
42. Changes in the proteomic profiles of mouse brain after infection with cyst-forming Toxoplasma gondii. Zhou DH, Zhao FR, Huang SY, Xu MJ, Song HQ, Su C, Zhu XQ, Parasit Vectors 2013 6 96 10.1186/1756-3305-6-96 23587304
43. Neuropathological stageing of Alzheimer-related changes. Braak H, Braak E, Acta Neuropathol 1991 82 239 259 10.1007/BF00308809 1759558
44. Could Toxoplasma gondii have any role in Alzheimer disease? Kusbeci OY, Miman O, Yaman M, Aktepe OC, Yazar S, Alzheimer Dis Assoc Disord 2011 25 1 3 10.1097/WAD.0b013e3181f73bc2 20921875
45. Toxoplasma gondii infection in the brain inhibits neuronal degeneration and learning and memory impairments in a murine model of Alzheimer's disease. Jung BK, Pyo KH, Shin KY, Hwang YS, Lim H, Lee SJ, Moon JH, Lee SH, Suh YH, Chai JY, Shin EH, PLoS One 2012 7 33312 10.1371/journal.pone.0033312 22470449
46. Rosiglitazone effects to ameliorate Alzheimer's disease pathogenic features: insulin signaling and neurotrophic factors. Castillo-Quan JI, J Neuropsychiatry Clin Neurosci 2009 21 347 348 10.1176/appi.neuropsych.21.3.347 19776322
47. Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Clodfelder-Miller BJ, Zmijewska AA, Johnson GV, Jope RS, Diabetes 2006 55 3320 3325 10.2337/db06-0485 17130475 (Pubitemid 44923588)
48. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A, Science 2005 308 1626 1629 10.1126/science.1109893 15860593 (Pubitemid 40807512)
49. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A, J Immunol 2002 168 5997 6001 12055206 (Pubitemid 34620012)
50. Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. Khan IA, Ely KH, Kasper LH, J Immunol 1994 152 1856 1860 7907106 (Pubitemid 24075718)
51. Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii. Lin SS, Gross U, Bohne W, Eukaryot Cell 2009 8 877 887 10.1128/EC.00381-08 19286986
52. Host metabolism regulates growth and differentiation of Toxoplasma gondii. Weilhammer DR, Iavarone AT, Villegas EN, Brooks GA, Sinai AP, Sha WC, Int J Parasitol 2012 42 947 959 10.1016/j.ijpara.2012.07.011 22940576